A report from the White Coat Waste Project that was based off a Freedom of Information Act request with the National Institutes of Allergy & Infectious Disease found that more than $400,000 in ...
Against a backdrop of low-volume but growing concerns about bird flu, the National Institutes of Health’s (NIH's) infectious disease arm has laid out its plans to study the virus that causes the ...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded 25 new grants to develop new and better diagnostics and treatments for ...
Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...
Tuberculosis (TB) is the leading infectious cause of death worldwide, killing roughly 1.6 million people in 2017. In the past 200 years, TB claimed the lives of more than one billion people--more ...
Please provide your email address to receive an email when new articles are posted on . Throughout his career as a physician and scientist, Fauci, who turns 82 on Dec. 24, has watched the field of ...
Biomedical researchers in government, academia and industry have made tremendous progress working collaboratively towards developing countermeasures for bioterrorism, according to a report issued ...
A universal vaccine—one that would work against all strains or variants of an infectious agent—is the long sought-after, holy grail, of vaccinations. For COVID-19, it would eliminate variant-specific ...
Please provide your email address to receive an email when new articles are posted on . The NIAID launched a phase 1 trial of a universal influenza vaccine. There are more than 30 trials trying to ...
Dr. Anthony Fauci’s longtime No. 2 is set to succeed him and assume the mantle of acting director of the National Institute of Allergy and Infectious Diseases. Surgeon Hugh Auchincloss will ascend to ...
The US National Institute of Allergy and Infectious Diseases (NIAID) and pharmaceutical company Moderna are seeking 30,000 volunteers for the largest clinical trial to date of their jointly developed ...